<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01242137</url>
  </required_header>
  <id_info>
    <org_study_id>169/09</org_study_id>
    <nct_id>NCT01242137</nct_id>
  </id_info>
  <brief_title>Pharmacogenetic Effect on the Pharmacodynamics of Glibenclamide</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <brief_summary>
    <textblock>
      Glibenclamide is metabolized by the hepatic enzyme P450 CYP2C9 to less active form.
      Polymorphism of this enzyme demonstrated clinical significance when examined on other drugs
      from the sulfonylurea drug family, to whom Glibenclamide is included.

      The investigators assumption is that patients with less active alleles of the enzyme may show
      lower dose requirements of the drug for glycemic control, when compared to patients
      homozygotes to wild-type alleles.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Extensive metabolizers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Intermediate mtabolizers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Poor metabolizers</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Diabetes type 2 patients treated with metformin and glibenclamide.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Tx with metformin and glibenclamide

        Exclusion Criteria:

          -  Tx which affecting the P450 2C9 action

          -  Renal failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amit Tirosh, Dr</last_name>
    <phone>972-52-4748989</phone>
    <email>tiroshamit@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assaf Harofe Medical Center</name>
      <address>
        <city>Beer Yakov</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amit Tirosh, Dr</last_name>
      <phone>972-52-4748989</phone>
      <email>tiroshamit@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Amit Tirosh, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2010</study_first_submitted>
  <study_first_submitted_qc>November 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2010</study_first_posted>
  <last_update_submitted>November 15, 2010</last_update_submitted>
  <last_update_submitted_qc>November 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2010</last_update_posted>
  <responsible_party>
    <name_title>Assaf Harofe Medical Center</name_title>
    <organization>Assaf Harofe Medical Center</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

